“…Regrowth has been reported in 38% to 95% of patients 4, 6, 12, 14, 17, 18. In these patients, current standard treatments include: 1) reoperation for patients with visual deterioration for opticochiasmatic decompression; 2) stereotactic radiosurgery , which is effective in patients with small adenoma remnants distant to the opticochiasmatic system31‐37; and 3) fractionated radiotherapy , which is reserved for the rare cases that are considered inoperable because of their fibrous consistency and unsuitable for radiosurgery because of large tumor size, location, and extension 14, 15, 31‐33, 38‐40. Although tumor control is achieved in up to 93% of patients,40 long‐term side effects of fractionated radiotherapy are common and include hypopituitarism, cerebrovascular disease, cognitive impairment, optic neuropathy, and the formation of secondary tumors as well as increased mortality 15, 31, 33, 38, 39, 41, 42…”